OANA BODEAN, OVIDIU BRATU, ROXANA BOHILTEA, OCTAVIAN MUNTEANU, DRAGOS MARCU, DAN ARSENIE SPINU, ILEANA ADELA VACAROIU, BOGDAN SOCEA, CAMELIA CRISTINA DIACONU, DELIA FOMETESCU GRADINARU, MONICA CIRSTOIU THE EFFICACY OF SYNTHETIC ORAL PROGESTIN PILLS IN PATIENTS WITH SEVERE ENDOMETRIOSIS Endometriosis is an important public health issues concerning women of reproductive age due to its debilitating painful symptoms. Deep infiltrating endometriosis is the severe form, involving uterosacral ligaments, rectum, bowel and bladder. There is no optimal treatment for this disease, but there are 3 main therapeutic options: medical, surgical and a combination of both. A modern approach for the treatment of endometriosis pain uses dienogest, a progestin, as a long-term solution for women who do not wish to procreate or to whom surgery is not an option. Dienogest 2mg daily has a positive effect on the reduction of pain and endometrial lesions when used perioperatively or as a long-term postoperative treatment. This article focuses on the literature evidence on the efficacy of newly approved oral synthetic progestins in the treatment of severe endometriosis.
Keywords: severe endometriosis, dienogest, pharmacological treatment